Prostate cancer survival rates improve as more men come forward
Key Points:
- Death rates from prostate cancer in England have decreased by 24% over seven years, with survival rates improving notably for men diagnosed with advanced stages of the disease.
- The National Prostate Cancer Audit reported a 7% increase in prostate cancer diagnoses in 2025, with metastatic cases rising from 5,696 in 2024 to 6,312 in 2025.
- Despite progress, nearly half of men diagnosed with incurable advanced prostate cancer still die within three years, highlighting the urgent need for earlier detection and a national screening programme targeting high-risk groups.
- Advances in treatments such as chemotherapy, hormone therapies, and radiotherapy have contributed to improved survival, but advocacy groups emphasize the importance of expanding targeted screening, especially for men with genetic risk factors and family history.
- There is a concerning rise in prostate cancer cases among men under 50, with diagnoses increasing from 158 cases in 2001 to 640 in 2023, underscoring the need for ongoing research and investment in prostate cancer care.